| For: | García AN, Sanz-Ruiz R, Santos MEF, Fernández-Avilés F. “Second-generation” stem cells for cardiac repair. World J Stem Cells 2015; 7(2): 352-367 [PMID: 25815120 DOI: 10.4252/wjsc.v7.i2.352] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v7/i2/352.htm |
| Number | Citing Articles |
| 1 |
Felix B. Engel. Stem Cells and Cardiac Regeneration. Stem Cell Biology and Regenerative Medicine 2016; doi: 10.1007/978-3-319-25427-2_8
|
| 2 |
Atlanta G. I. M. Elie, Pia S. Jensen, Katrine D. Nissen, Ilvy M. E. Geraets, Aimin Xu, Erfei Song, Maria L. Hansen, Akhmadjon Irmukhamedov, Lars M. Rasmussen, Yu Wang, Jo G. R. De Mey, Alexander G Obukhov. Adipokine Imbalance in the Pericardial Cavity of Cardiac and Vascular Disease Patients. PLOS ONE 2016; 11(5) doi: 10.1371/journal.pone.0154693
|
| 3 |
Patrizia Nigro, Beatrice Bassetti, Laura Cavallotti, Valentina Catto, Corrado Carbucicchio, Giulio Pompilio. Cell therapy for heart disease after 15 years: Unmet expectations. Pharmacological Research 2018; 127 doi: 10.1016/j.phrs.2017.02.015
|
| 4 |
Miruna Mihaela Micheu, Alina Ioana Scarlatescu, Alexandru Scafa-Udriste, Maria Dorobantu. The Winding Road of Cardiac Regeneration—Stem Cell Omics in the Spotlight. Cells 2018; 7(12) doi: 10.3390/cells7120255
|
| 5 |
Andrey A. Karpov, Maxim V. Puzanov, Dmitry Yu. Ivkin, Marina V. Krasnova, Nikita A. Anikin, Pavel M. Docshin, Olga M. Moiseeva, Michael M. Galagudza. Non‐inferiority of microencapsulated mesenchymal stem cells to free cells in cardiac repair after myocardial infarction: A rationale for using paracrine factor(s) instead of cells. International Journal of Experimental Pathology 2019; 100(2) doi: 10.1111/iep.12312
|
| 6 |
Ricardo Sanz-Ruiz, Francisco Fernández-Avilés. Autologous and allogeneic cardiac stem cell therapy for cardiovascular diseases. Pharmacological Research 2018; 127 doi: 10.1016/j.phrs.2017.05.024
|
| 7 |
Cosmin Alexandru Buzilă, Mircea Ifrim, Andreea Loredana Micu. Coronary Graft Failure. 2016; doi: 10.1007/978-3-319-26515-5_66
|
| 8 |
Pavel M. Docshin, Andrei A. Karpov, Malik V. Mametov, Dmitry Y. Ivkin, Anna A. Kostareva, Anna B. Malashicheva. Mechanisms of Regenerative Potential Activation in Cardiac Mesenchymal Cells. Biomedicines 2022; 10(6) doi: 10.3390/biomedicines10061283
|
| 9 |
Lina Badimon, Guiomar Mendieta, Gemma Vilahur, Maria Borrell-Pages. Current Approach to Heart Failure. 2025; doi: 10.1007/978-3-031-96562-3_15
|
| 10 |
Annu Nummi, Tuomo Nieminen, Tommi Pätilä, Milla Lampinen, Miia L. Lehtinen, Sari Kivistö, Miia Holmström, Erika Wilkman, Kari Teittinen, Mika Laine, Juha Sinisalo, Markku Kupari, Esko Kankuri, Tatu Juvonen, Antti Vento, Raili Suojaranta, Ari Harjula. Epicardial delivery of autologous atrial appendage micrografts during coronary artery bypass surgery—safety and feasibility study. Pilot and Feasibility Studies 2017; 3(1) doi: 10.1186/s40814-017-0217-9
|
| 11 |
Rosalinda Madonna, Linda W. Van Laake, Sean M. Davidson, Felix B. Engel, Derek J. Hausenloy, Sandrine Lecour, Jonathan Leor, Cinzia Perrino, Rainer Schulz, Kirsti Ytrehus, Ulf Landmesser, Christine L. Mummery, Stefan Janssens, James Willerson, Thomas Eschenhagen, Péter Ferdinandy, Joost P.G. Sluijter. Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. European Heart Journal 2016; 37(23) doi: 10.1093/eurheartj/ehw113
|
| 12 |
Teresa Simon-Yarza, Isabelle Bataille, Didier Letourneur. Cardiovascular Bio-Engineering: Current State of the Art. Journal of Cardiovascular Translational Research 2017; 10(2) doi: 10.1007/s12265-017-9740-6
|
| 13 |
Kathleen M. Broughton. Prevalence of comorbidities in heart failure patients and those treated with cellular therapeutics. Expert Review of Cardiovascular Therapy 2019; 17(8) doi: 10.1080/14779072.2019.1653185
|
| 14 |
Khawaja Husnain Haider. Priming mesenchymal stem cells to develop “super stem cells”. World Journal of Stem Cells 2024; 16(6): 623-640 doi: 10.4252/wjsc.v16.i6.623
|
| 15 |
Andrey A. Karpov, Daria V. Udalova, Michael G. Pliss, Michael M. Galagudza. Can the outcomes of mesenchymal stem cell‐based therapy for myocardial infarction be improved? Providing weapons and armour to cells. Cell Proliferation 2017; 50(2) doi: 10.1111/cpr.12316
|
| 16 |
Lina Badimon, Gemma Vilahur, Judit Cubedo. Current Approach to Heart Failure. 2016; doi: 10.1007/978-3-319-45237-1_16
|
| 17 |
Andre Terzic, Atta Behfar. Stem cell therapy for heart failure: Ensuring regenerative proficiency. Trends in Cardiovascular Medicine 2016; 26(5) doi: 10.1016/j.tcm.2016.01.003
|